Sign inJoin waitlistJoin the waitlist

OM

Ostap Melnyk

Hematology & Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
1988–1991
Internal Medicine
1985–1988
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1981–1985

Research

Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non…
Journal of Clinical Oncology · 2007 · 352 citations
Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth
Cancer Research · 1996 · First of 3 authors · 123 citations
Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model
The Journal of Urology · 1999 · First of 4 authors · 122 citations

GB
Gail Brown
2 papers
Lowell Hart
2 papers
Marc Shuman
2 papers
RB
Ralph Boccia
2 papers
RB
Robert Brasch
2 papers
RH
Roy Herbst
2 papers
Carolyn Runowicz
1 paper
CB
Chandra Belani
1 paper
CE
Craig Englund
1 paper
EM
Erminia Massarelli
1 paper · 1 as a resident
Glenn Mills
1 paper
HB
Howard Burris
1 paper